Carisma Therapeutics (CARM) Stock Chart & Stock Price History $0.20 +0.00 (+2.22%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Carisma Therapeutics Stock Price Performance 5 Day Performance-10.66%1 Month Performance-9.14%3 Month Performance-56.09%6 Month Performance-79.81%Year-To-Date Performance-51.79%1 Year Performance-87.38% Receive CARM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CARM Stock Chart for Friday, May, 2, 2025 CARM Chart by TradingView Carisma Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$0.20$0.20+1.66%$0.21$0.20112,716 shs$8.44 million04/30/2025$0.20$0.20-2.26%$0.21$0.19159,807 shs$8.30 million04/29/2025$0.20$0.20-0.39%$0.21$0.1994,767 shs$8.49 million04/28/2025$0.23$0.20-9.73%$0.23$0.20181,581 shs$8.53 million04/25/2025$0.22$0.23+5.02%$0.23$0.2173,333 shs$9.44 million04/24/2025$0.22$0.22-1.24%$0.23$0.21281,673 shs$8.99 million04/23/2025$0.21$0.22+2.83%$0.23$0.2188,452 shs$9.11 million04/22/2025$0.19$0.21+11.88%$0.21$0.18131,189 shs$8.86 million04/21/2025$0.19$0.19-1.35%$0.20$0.18163,252 shs$7.92 million04/18/2025$0.19$0.19$0.21$0.18218,192 shs$8.02 million Get the Latest News and Ratings for CARM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$0.20$0.19-4.43%$0.21$0.18218,192 shs$8.02 million04/16/2025$0.20$0.20+1.98%$0.21$0.2050,400 shs$8.40 million04/15/2025$0.21$0.20-7.64%$0.22$0.20189,529 shs$8.23 million04/14/2025$0.21$0.21+3.04%$0.22$0.2075,750 shs$8.65 million04/11/2025$0.20$0.21+4.02%$0.21$0.1995,079 shs$8.65 million04/10/2025$0.20$0.20+0.66%$0.21$0.1981,573 shs$8.32 million04/09/2025$0.18$0.20+12.33%$0.21$0.18156,570 shs$8.26 million04/09/2025$0.18$0.20+12.33%$0.21$0.18156,570 shs$8.26 million04/08/2025$0.19$0.18-8.81%$0.21$0.18187,606 shs$7.36 million04/08/2025$0.19$0.18-8.81%$0.21$0.18187,606 shs$7.36 million04/07/2025$0.19$0.19+0.73%$0.19$0.16309,728 shs$8.07 million04/04/2025$0.19$0.19-0.26%$0.22$0.17818,840 shs$8.00 million04/03/2025$0.22$0.19-13.55%$0.22$0.18403,813 shs$8.02 million04/02/2025$0.23$0.22-3.60%$0.23$0.20646,862 shs$9.28 million04/01/2025$0.31$0.23-25.65%$0.30$0.20924,645 shs$9.62 million Related Companies Surrozen Stock Price Chart Barinthus Biotherapeutics Stock Price Chart AlloVir Stock Price Chart Cadrenal Therapeutics Stock Price Chart LAVA Therapeutics Stock Price Chart Pluri Stock Price Chart FibroGen Stock Price Chart Aligos Therapeutics Stock Price Chart Alterity Therapeutics Stock Price Chart Marinus Pharmaceuticals Stock Price Chart Receive CARM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CARM) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carisma Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carisma Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CARM Stock Free CARM Stock Alerts